Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0507 per EA under NDC 68645056354. Its NADAC has been published 466 times since Dec 20, 2017.

FDA first approved this application on Sep 15, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0507per EA

Strength

800 mg/1

NDC

68645056354

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA091625

FDA Approved

9/15/2015

TE Code

AB

On Market Since

12/21/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 466 times since Dec 20, 2017, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0507 per EA
All-time high$0.0933 (Mar 11, 2020)
All-time low$0.0483 (Dec 20, 2017)
52-week high$0.0585
52-week low$0.0507
Median price$0.0673
Average price$0.0683
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked466
Tracking sinceDec 20, 2017

Price History

1W

-8.6%

1M

-11.4%

3M

-13.3%

6M

-10.6%

1Y

-11.0%

3Y

-22.1%

5Y

-35.3%

All

+4.9%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0507 per EA (NDC 68645056354), effective Nov 18, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has risen 4.9%. It has been tracked across 466 weekly CMS publications since Dec 20, 2017.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Dec 20, 2017, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0483 (Dec 20, 2017) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0673 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 68645056354) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.